Used During Pandemic, Telehealth Lowered U.S. Opioid Overdoses
FRIDAY, Sept. 2, 2022 (HealthDay News) — Telehealth flourished during the pandemic, and now a new study shows it saved lives: The practice meant more people struggling with opioid addiction stayed in treatment longer and thereby lowered their risk of…
Learn MoreUn estudio del cerebro muestra cómo el fentanilo acaba con la vida
MIÉRCOLES, 31 de agosto de 2022 (HealthDay News) — El fentanilo, el opioide sintético que fomenta un aumento en las muertes por sobredosis, acaba con la vida al parar la respiración incluso antes de que alguien pierda la consciencia, revela un nuevo …
Learn MoreUn estudio del cerebro muestra cómo el fentanilo acaba con la vida
MIÉRCOLES, 31 de agosto de 2022 (HealthDay News) — El fentanilo, el opioide sintético que fomenta un aumento en las muertes por sobredosis, acaba con la vida al parar la respiración incluso antes de que alguien pierda la consciencia, revela un nuevo …
Learn MoreDeadly ‘Rainbow Fentanyl’ Looks Like Candy, Could Entice Kids
THURSDAY, Sept. 1, 2022 (HealthDay News) — The U.S. Drug Enforcement Administration (DEA) is warning the public that colorfully dyed fentanyl — dubbed “rainbow fentanyl” — is readily available across the United States. “Rainbow fentanyl — fentanyl pi…
Learn MoreRisk for Neonatal Opioid Withdrawal Syndrome Examined
WEDNESDAY, Aug. 31, 2022 (HealthDay News) — Neonates exposed to strong agonists and long half-life prescription opioids in the third trimester of pregnancy have an increased risk for neonatal opioid withdrawal syndrome (NOWS), according to a study pu…
Learn MoreBrain Study Shows How Fentanyl Kills
WEDNESDAY, Aug. 31, 2022 (HealthDay News) — Fentanyl, the synthetic opioid that’s driving a surge in drug overdose deaths, kills by stopping breathing even before someone loses consciousness, a new study reveals. To come to that conclusion, researche…
Learn MoreMuchos de los que más necesitan el antídoto para una sobredosis de opioides no pueden permitírselo
LUNES, 22 de agosto de 2022 (HealthDay News) — La naloxona es un antídoto para la sobredosis de opioides que salva vidas, pero quizá su precio sea demasiado alto para los más vulnerables a una muerte relacionada con los opioides, encuentra un estudio…
Learn MoreOut-of-Pocket Costs for Naloxone Up for Uninsured Patients
TUESDAY, Aug. 23, 2022 (HealthDay News) — The out-of-pocket (OOP) cost for naloxone has grown and poses a substantial barrier to access for uninsured patients, according to a study published online Aug. 19 in JAMA Health Forum.
Evan D. Peet, Ph.D…
Learn MoreApartan a los opioides del tratamiento del dolor dental
VIERNES, 19 de agosto de 2022 (HealthDay News) — Muchas personas que abusan de los opioides citan un uso legítimo a corto plazo de un opioide para el alivio del dolor de una articulación o dental como su “entrada” a la adicción.Ahora, una investigaci…
Learn MoreMany Who Need Opioid OD Antidote the Most Can’t Afford It
MONDAY, Aug. 22, 2022 (HealthDay News) — Naloxone is a lifesaving antidote to an opioid overdose, but it may be priced too high for those most vulnerable to opioid-related death, a new study finds.Between 2014 and 2018, naloxone costs rose 500% for t…
Learn More